Document is current
Any future updates will be listed below
-
Authors
Sen, Swapnoleena
Braunack-Mayer, Lydia
Kelly, Sherrie L.
Masserey, Thiery
Malinga, Josephine
Moehrle, Joerg J.
Penny, Melissa A.
-
Funding
Funding for this research was provided by:
Bill & Melinda Gates Foundation (INV-025569 (to Melissa A Penny))
Bill & Melinda Gates Foundation (INV-002562 (to Melissa A Penny))
Bill & Melinda Gates Foundation (INV-002562 (to Melissa A Penny))
Bill & Melinda Gates Foundation (INV-025569 (to Melissa A Penny))
Swiss National Science Foundation (SNF Professorship PP00P3_170702 and PP00P3_203450 (to Melissa A Penny))
Swiss National Science Foundation (SNF Professorship PP00P3_170702 and PP00P3_203450 (to Melissa A Penny))
- License Information
-
More Information
Article History
Received: 18 September 2024
Accepted: 7 March 2025
First Online: 26 March 2025
Declarations
:
: The authors declare no competing interests.
: Joerg J Moehrle was employed by Medicines for Malaria Venture. Melissa A. Penny was a member of the WHO Guidelines Development Group for Malaria Chemoprevention in 2020–2021. All other authors declare no competing financial or non-financial interests.
